Innovative MedTech, Inc. announced the formation of its new scientific advisory board (‘SAB'), which the company anticipates will be comprised of leading experts in healthcare and gerontology. The first member of the company's SAB will be Dr. Roscoe Moore DVM, M.P.H., Ph.D. (‘Dr. Moore'). The Scientific Advisory Board (‘SAB') is expected to play a crucial role in providing strategic guidance and scientific expertise to the Company as it seeks to provide the quality of care and to expand its services.

The SAB will be responsible for reviewing and evaluating scientific research and best practices related to adult day care, identifying emerging trends and opportunities, assist the Company with a legislative agenda and develop strategies and recommendations to expand and improve the quality of care provided by the Company. Dr. Moore served as an Epidemic Intelligence Service Officer with the Centers for Disease Control and Prevention (CDC), and as an Assistant United States Surgeon General under three Presidential Administrations, and served as the U.S. Chief Veterinary Medical Officer appointed by former U.S. Surgeon General C. Everett Koop. He has also served as a Senior Epidemiologist for the United States Department of Health and Human Services (HHS), and as the Chief Medical Officer of the United States Department of Agriculture's (USDA) Food Safety and Inspection Service.

Dr. Moore served in the Office of the US Secretary of Health and Human Services, held the position of Associate Director for Development Support and African Affairs for the Department of Health and Human Services (HHS), and served as the chief epidemiologist with the Centers of Devices and Radiological Health in the US Food and Drug Administration (FDA). Dr. Moore is the Founder and President of PH Rockwood LLC. Dr. Moore has a Ph.D. in Epidemiology from The Johns Hopkins University, an M.P.H. in Epidemiology from the University of Michigan, and a Doctor of Veterinary Medicine and a B.S. degree from Tuskegee Institute; he also has received an honorary D.Sc.

degree from Tuskegee University in recognition of his distinguished public health career. Dr. Moore has written or co-authored over 100 publications covering a broad range of public health issues. Dr. Moore serves on the Scientific Advisory Board Member of Immgenuity, Inc., Napo Pharmaceuticals, Arev Life Sciences Global Corp, A Legacy Genetics, and Cera Products Incorporated, as well as being a member of the Board of Directors of OyaGen, Inc., a Senior Fellow at Potomac Institute for Policy Studies, and a Board of Advisor Member of the Institute of Human Virology at the University of Maryland School of Medicine.